Cargando…

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy

Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare form of primary liver cancer composed of cells with histopathologic features of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). Because of its low incidence, the information on clinical outcomes of cHCC-CC is very limite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Gun Min, Jeung, Hei-Cheul, Kim, Dokyung, Kim, Joo Hoon, Yoon, Sang Hyun, Jung, Eun Suk, Shin, Sang Joon
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021743/ https://www.ncbi.nlm.nih.gov/pubmed/21253326 http://dx.doi.org/10.4143/crt.2010.42.4.235

Ejemplares similares

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
por: Kim, Sang-Won, et al.
Publicado: (2023)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
por: Chon, Hong Jae, et al.
Publicado: (2011)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report
por: Nugroho, Adianto, et al.
Publicado: (2018)

CD44 expression in patients with combined hepatocellular cholangiocarcinoma
por: Kim, Ryounggo, et al.
Publicado: (2015)

Clinicopathological Characteristics in Combined Hepatocellular-Cholangiocarcinoma: A Single Center Study in Korea
por: Park, Hana, et al.
Publicado: (2011)

Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma
por: Shin, Seung Kak, et al.
Publicado: (2018)

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
por: Park, Se Hoon, et al.
Publicado: (2006)

Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
por: Kim, Jongman, et al.
Publicado: (2023)

Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype
por: Yi, Seong Yoon, et al.
Publicado: (2010)

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection
por: Na, Seong Kyun, et al.
Publicado: (2018)

Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma
por: Park, Sang Eun, et al.
Publicado: (2013)

Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging
por: Kim, Yeun‐Yoon, et al.
Publicado: (2021)

Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
por: Kim, Hong Jun, et al.
Publicado: (2020)

Association between Skeletal Muscle Loss and the Response to Neoadjuvant Chemotherapy for Breast Cancer
por: Lee, Byung Min, et al.
Publicado: (2021)

Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
por: Jeung, Hei-Cheul, et al.
Publicado: (2010)

Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
por: Park, Semi, et al.
Publicado: (2009)

Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
por: Kobayashi, Satoshi, et al.
Publicado: (2018)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
por: Renzulli, Matteo, et al.
Publicado: (2021)

Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions
por: Kim, Ki-Yeol, et al.
Publicado: (2008)

A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult
por: Park, Keun Woo, et al.
Publicado: (2015)

A Case of Combined Hepatocellular-Cholangiocarcinoma with Underlying Schistosomiasis
por: Hong, Chang Kyun, et al.
Publicado: (2007)

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
por: Yoon, Hong In, et al.
Publicado: (2016)

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
por: Choi, Joon Hyuk, et al.
Publicado: (2022)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Novel and simple transformation algorithm for combining microarray data sets
por: Kim, Ki-Yeol, et al.
Publicado: (2007)

Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma
por: Kim, Gi Jeong, et al.
Publicado: (2013)

Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer
por: Kim, Seung Tae, et al.
Publicado: (2012)

Cervical Facet Joint Injections in the Neck and Shoulder Pain
por: Kim, Kyung-Hoon, et al.
Publicado: (2005)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy
por: Kim, Seong Hyeon, et al.
Publicado: (2019)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver
por: Wang, Jue, et al.
Publicado: (2010)

Current update on combined hepatocellular-cholangiocarcinoma
por: Maximin, Suresh, et al.
Publicado: (2014)

Combined hepatocellular-cholangiocarcinoma in a cow
por: HONDA, Hidetsugu, et al.
Publicado: (2019)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells
por: Kim, Han Sang, et al.
Publicado: (2012)

The impact of portal vein resection on outcome of hilar cholangiocarcinoma
por: Kim, Ki Beom, et al.
Publicado: (2021)

Propofol protects against lipopolysaccharide-induced inflammatory response in human amnion-derived WISH cells
por: Kim, Cheul-Hong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ci78b7km0pbsc3fu0pm7hutbm